133 related articles for article (PubMed ID: 3553239)
21. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
22. ["Benign" monoclonal gammopathy: prognostic value of initial bone marrow study].
Grau E; Ayats R; Puig J; Domingo A; Pujol-Moix N
Sangre (Barc); 1985; 30(3):308-19. PubMed ID: 4035526
[No Abstract] [Full Text] [Related]
23. Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease.
Brady K; Corash L; Bhargava V
Arch Pathol Lab Med; 1997 Oct; 121(10):1108-11. PubMed ID: 9341594
[TBL] [Abstract][Full Text] [Related]
24. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
[TBL] [Abstract][Full Text] [Related]
25. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
26. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
[TBL] [Abstract][Full Text] [Related]
27. Paraproteinaemia: use of idiotypic determinants as specific markers for tumour activity.
King MA; Vivianwells J
Clin Exp Immunol; 1981 Sep; 45(3):544-51. PubMed ID: 6175454
[TBL] [Abstract][Full Text] [Related]
28. IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.
Mayumi M; Kuritani T; Kubagawa H; Cooper MD
J Immunol; 1983 Feb; 130(2):671-7. PubMed ID: 6217248
[TBL] [Abstract][Full Text] [Related]
29. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
Perfetti V; Vignarelli MC; Bellotti V; Glennie MJ; Zorzoli I; Ubbiali P; Obici L; Massa M; Ippoliti G; Ascari E; Merlini G
Lab Invest; 1997 Oct; 77(4):333-44. PubMed ID: 9354768
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry.
Thiele J; Arenz B; Klein H; Vierbuchen M; Zankovich R; Fischer R
Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):553-62. PubMed ID: 3129867
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of benign monoclonal gammopathy and smouldering multiple myeloma from frank myeloma.
Shimizu K; Ohnishi K; Kunii A
Clin Exp Immunol; 1982 Dec; 50(3):596-600. PubMed ID: 6819908
[TBL] [Abstract][Full Text] [Related]
32. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
[TBL] [Abstract][Full Text] [Related]
33. Histomorphology of multiple myeloma on bone marrow biopsy.
Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
[TBL] [Abstract][Full Text] [Related]
34. Nonsecretory myeloma: analysis of two patients by immunoperoxidase studies and plaque-forming cell assay.
Matsuzaki H; Kagimoto T; Matsushita S; Matsuoka M; Tajima H; Yamamura F; Takatsuki K
Jpn J Clin Oncol; 1985 Jun; 15(2):467-73. PubMed ID: 3894717
[TBL] [Abstract][Full Text] [Related]
35. In vitro immunoglobulin production in mitogen-stimulated cultures of peripheral blood and bone marrow cells from young and old adults, and cases of benign monoclonal gammopathy.
Suzuki K; Hosoi T; Urabe A; Takaku F
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):756-62. PubMed ID: 2618550
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic value of the MB2 monoclonal antibody in paraffin-embedded bone marrow sections of patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
Dehou MF; Schots R; Lacor P; Arras N; Verhavert P; Klöppel G; van Camp B
Am J Clin Pathol; 1990 Sep; 94(3):287-91. PubMed ID: 1697732
[TBL] [Abstract][Full Text] [Related]
37. Detection of B-cells clonally related to the tumor population in multiple myeloma and MGUS.
Billadeau D; Greipp P; Ahmann G; Witzig T; Van Ness B
Curr Top Microbiol Immunol; 1995; 194():9-16. PubMed ID: 7895525
[No Abstract] [Full Text] [Related]
38. Immunocytochemical studies of human myeloma cells by light and electron microscopy.
Biberfeld P; Mellstedt H; Pettersson D
Isr J Med Sci; 1979 Aug; 15(8):687-92. PubMed ID: 383646
[TBL] [Abstract][Full Text] [Related]
39. Colony assay in patients with multiple myeloma--relationship between colony growth and clinical stage.
Otsuka T; Okamura S; Niho Y
Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1792-9. PubMed ID: 3105210
[No Abstract] [Full Text] [Related]
40. Coincident multiple myeloma and non-Hodgkin's lymphoma with 2 serum monoclonal immunoglobulins.
Grau E; Soler J; Puig J; Brunet S; Pujol-Moix N; Rodriguez JL; Domingo-Albós A
Acta Haematol; 1986; 75(3):183-5. PubMed ID: 3092538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
